Company: STAA
Filing Date: 2025-09-30
Form Type: DEFA14A
Source: 0001193125-25-224160
Chunk: 5

Company: STAAR SURGICAL CO
Filing Date: 2025-09-30
Form: DEFA14A
Chunk 5
---
 decline significantly if the proposed transaction is not consummated; and (9) other important factors set forth under the caption “Risk Factors” in each of the
Proxy Statement, Alcon’s Annual Report on Form 20-F for the fiscal year ended December 31, 2024, and STAAR’s Annual Report on Form 10-K for the year
ended December 27, 2024, as any such factors may be updated from time to time in STAAR’s and Alcon’s other filings with the SEC, as applicable.

Forward-looking statements speak only as of the date they are made and, except as may be required under applicable law, Alcon and STAAR undertake no
obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Alcon Investor Relations

Daniel Cravens, Allen Trang

+ 41 589 112
110 (Geneva)

+ 1 817 615 2789 (Fort Worth)

investor.relations@alcon.com

Alcon Media Relations

Steven Smith

+ 41 589 112 111 (Geneva)

+ 1 817 551 8057 (Fort Worth)

globalmedia.relations@alcon.com

STAAR Investor Relations

Niko Liu, CFA

United States: +1 626-303-7902 (ext 3023)

Hong Kong: +852-6092-5076

nliu@staar.com

investorrelations@staar.com

STAAR Media Relations

Connie Johnson

+1 626-303-7902 (ext 2207)

cjohnson@staar.com

Lucas Pers / Alexandra Benedict

Joele Frank, Wilkinson Brimmer Katcher

+1 212-895-8692 / +1 212-895-8644

4